Related by context. All words. (Click for frequent words.) 69 small molecule inhibitors 69 therapeutics 68 monoclonal antibodies 67 peptide 66 preclinical 66 therapeutic antibodies 66 orally bioavailable 66 monoclonal antibody 66 MEK inhibitor 66 peptides 66 small molecule inhibitor 66 novel peptide 65 cancer therapeutics 65 kinase inhibitor 65 siRNA therapeutics 65 antibody 65 therapeutic antibody 65 siRNA 64 therapeutic monoclonal antibodies 64 kinase inhibitors 64 antisense drugs 64 proteasome inhibitors 64 anticancer therapeutics 64 humanized monoclonal antibody 64 antisense 64 epothilone 63 novel immunomodulatory 63 antibody therapeutics 63 novel therapeutics 63 siRNA therapeutic 63 Fc fusion protein 63 small molecule therapeutics 63 disease modifying 63 Anticalin 63 epothilones 63 biotherapeutics 62 HDAC inhibitor 62 inhibitor 62 novel anti infective 62 small molecule agonists 62 antisense drug 62 anticancer agents 62 protein therapeutics 62 PI3K inhibitor 62 HDAC inhibitors 62 preclinical compounds 62 protein kinase inhibitors 62 Locked Nucleic Acid LNA 62 MEK inhibitors 62 histone deacetylase 62 generation antisense 62 Nanobodies 62 ErbB3 HER3 62 aptamers 62 SGLT inhibitors 62 IAP inhibitor 61 RNAi 61 tyrosine kinase inhibitor 61 biotherapeutic 61 therapeutic proteins 61 liposomal formulation 61 targeted radiotherapeutic 61 immunotherapeutic 61 potently inhibit 61 immunotherapeutics 61 pharmacological chaperone 61 GPCR 61 histone deacetylase HDAC inhibitors 61 HCV protease 61 humanized monoclonal antibodies 61 Preclinical studies suggest 61 synthetic peptide 61 investigational drug 61 small molecule tyrosine 61 kinase 61 humanized antibody 61 selective inhibition 61 RNAi therapeutics 61 selective inhibitors 61 prodrug 61 TLR9 agonist 61 therapeutic monoclonal antibody 61 JAK inhibitor 61 selective inhibitor 61 HSP# inhibitor 61 exon skipping 61 aptamer 61 investigational humanized monoclonal antibody 61 PDE4 inhibitor 61 CB2 selective 61 PI3K/mTOR 61 medicinal chemistry 61 MTP inhibitor 60 IAP inhibitors 60 novel orally administered 60 selective androgen receptor modulators 60 immunomodulator 60 histone methyltransferases HMTs 60 Anticalins 60 G Protein Coupled 60 vascular disrupting agents 60 oligonucleotide 60 GPCR targets 60 preclinical studies 60 synthetic peptides 60 selective kinase inhibitor 60 PROfusion 60 proteasome inhibitor 60 RNA antagonists 60 novel anticancer 60 CTLA4 Ig 60 peptibody 60 KineMed 60 Hsp# inhibitors 60 anti infective 60 BiTE 60 Hsp# inhibitor 60 DOS# 60 anti angiogenic 60 small molecule activators 60 multi kinase inhibitor 60 molecularly targeted 60 isoform selective 60 rxRNA 60 Alfacell proprietary ribonuclease 60 peptidic 60 Tranzyme 60 PORxin TM 59 inflammatory diseases 59 antibody fragment 59 siRNAs 59 immunomodulatory 59 histone deacetylase HDAC inhibitor 59 TLR Therapeutics 59 recombinant protein 59 JAK1 59 MDRNA proprietary 59 novel antiviral therapeutics 59 pan HDAC inhibitor 59 Fleximer 59 Nanobody 59 selectively inhibit 59 VEGF receptor 59 Anticalins R 59 adrenal steroid hormones 59 biopharmaceutical 59 small molecule modulators 59 THR beta agonist 59 small molecule defensin 59 novel peptides 59 polymerase inhibitors 59 polymerase inhibitor 59 XmAb ™ 59 RNA antagonist 59 Receptos 59 anticancer drugs 59 biologic therapeutics 59 liposomal 59 Squalamine 59 oral prodrug 59 molecule 59 FGFR 59 signal transduction inhibitor 59 JAK2 inhibitor 59 preclinical models 59 selectively inhibits 59 molecular chaperone 59 RNAi therapeutic 59 AMPAKINE 59 ion channel 59 potent inhibitor 59 siRNA delivery 59 Epothilones 59 reversible inhibitor 59 protein kinase inhibitor 59 vinca alkaloid 59 anticoagulant reversing agent 59 proprietary LNA 59 AEG# 59 HSP# inhibitors 59 histone deacetylase HDAC 59 small interfering RNA 59 TLR8 59 #ME# 59 5 HT2A receptor 59 BN# [002] 59 Enkephalin 59 PARP inhibitor 58 HDAC 58 induce apoptosis 58 IMiDs R 58 agonists 58 nitric oxide donating 58 oncolytic 58 deacetylase inhibitors 58 CB1 antagonists 58 molecules 58 protease 58 short interfering RNA 58 throughput screening 58 synthetic retinoid 58 molecular biomarkers 58 oncology therapeutics 58 bioactive lipids 58 partial agonist 58 sphingosine 1 58 biocatalysts 58 small molecule glucokinase 58 fusion proteins 58 immunotherapies 58 human monoclonal antibody 58 orally administered 58 nicotinic acetylcholine receptor 58 Anticalin R 58 Factor VIIa 58 agonist 58 TLR9 agonists 58 histone deacetylase inhibitor 58 recombinant antibodies 58 oxazolidinone 58 therapeutic 58 personalized immunotherapy 58 chemically modified siRNA 58 Protein Kinase C 58 Nanobody ® 58 OMP #M# 58 GPCRs 58 biased ligand 58 anticancer compounds 58 ligands 58 RNA interference RNAi 58 immune modulation 58 humanized anti 58 enzyme inhibitor 58 novel prodrug 58 siRNA compounds 58 SARMs 58 HepDirect 58 biologic 58 M2 subunit 58 Hsp# inhibition 58 anticancer therapies 58 AKT inhibitor 58 anticancer 58 antagomirs 58 anticancer agent 58 neurodegenerative diseases 58 antitumor 58 HepDirect R 58 prodrugs 58 angiogenesis inhibitor 58 BiTE antibody 58 ALN TTR 58 Hedgehog pathway 58 PEGylated 58 NuMimetic TM 58 mitotic kinesin 58 polyketide 58 NEUGENE 58 human antibody therapeutics 58 vascular disrupting agent 58 Hedgehog signaling pathway 58 CEQ# 58 Archexin 58 stem cell therapeutics 58 A3 adenosine receptor 58 Fibroblast Growth Factor Receptor 58 peptide therapeutics 58 TLR9 58 Receptors GPCRs 58 Stapled Peptide 58 novel RNAi therapeutics 58 nanoparticle formulation 58 mitogen activated ERK kinase 58 Gemin X 57 immune modulators 57 biomarker 57 immune modulatory 57 vivo 57 γ secretase 57 humanized antibodies 57 ArQule Kinase Inhibitor Platform 57 therapeutic peptides 57 sodium glucose cotransporter 57 LNP formulations 57 antisense oligonucleotide 57 novel kinase inhibitors 57 HCV NS3 protease 57 PI3K 57 Onconase 57 Panzem 57 Talabostat 57 multitargeted 57 receptor antagonist 57 AMPAKINE compounds 57 ESBA# 57 adenosine receptor 57 AAG geldanamycin analog 57 sodium glucose transporter 57 cancer immunotherapies 57 Aganocide ® 57 biased ligands 57 CCR9 antagonist 57 histone deacetylase inhibitors 57 NTDDS 57 biomarker discovery 57 ChemoCentryx 57 defensin mimetic antibiotic 57 oral antiviral 57 HepDirect prodrug 57 oxidative stress inducer 57 neuroprotective properties 57 prolyl hydroxylase inhibitors 57 engineered proteases 57 Locked Nucleic Acid 57 compounds 57 HDAC inhibition 57 antitumoral 57 CB2 selective receptor agonist 57 anti secretory 57 Tyrima 57 tranilast 57 PARP inhibitors 57 Tarvacin TM 57 OXIGON TM 57 bifunctional 57 Debio 57 therapeutic peptide 57 polysaccharide polymer 57 IIB ActRIIB 57 HQK 57 carbohydrate polymer 57 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 57 adenosine A2A 57 immune stimulatory 57 PI3K inhibitors 57 hypoxia inducible factor 57 Vaccinex 57 ALN TTR# 57 mAb 57 biomarkers 57 GPR# agonist 57 Fleximer R 57 antiviral therapeutics 57 fusion protein 57 rFVIIIFc 57 ErbB3 57 optical biosensors 57 neuronal nicotinic receptors NNRs 57 stable nucleic acid 57 ENMD # 57 Curaxins 57 E2F 57 phage display 57 microtubule inhibitor 57 microRNA therapeutics 57 KinomeScan 57 Anticalins ® 57 agonist compounds 57 targeting CD# 57 targeted antifolate 57 NEUGENE antisense 57 allosteric modulator 57 potent inhibitors 57 Pentad TM 57 GRN#L 57 Aganocide 57 enhance ApoA 57 Metallophile ™ Technology 57 investigational compounds 57 Charlesson 57 cytotoxic 57 Vidofludimus 57 LNPs 57 tiapamil 57 ALN PCS 57 TLR8 agonist 57 antisense inhibitor 57 anti angiogenesis 57 gene silencing 57 JAK inhibitors 57 melanocortin receptor agonists 57 investigational therapies 57 dAbs 57 chemotherapeutic agent 57 liposomal delivery 57 synthetic siRNA 57 Spiegelmers ® 57 novel orally bioavailable 57 antisense oligonucleotides 56 NNRs 56 Smac mimetics 56 peripherally acting 56 ocular diseases 56 TLR7 56 receptor agonist 56 TLR agonists 56 Onalta 56 Sym# 56 Friedreich Ataxia FRDA 56 CYT# potent vascular disrupting 56 humanized monoclonal 56 JAK3 56 monoclonal 56 Celator 56 enzyme inhibitors 56 adenoviral 56 Adnectin 56 Pathway Inhibitor 56 investigational pan BCR 56 antibiotic anti infective 56 CNS disorders 56 renin inhibitors 56 SAR# [002] 56 Omacetaxine 56 VitiGam 56 mda 7 56 receptor agonists 56 p# inhibitors 56 anti CD3 56 sigma receptors 56 Panzem R 56 Olaparib 56 JAK3 inhibitor 56 nicotinic alpha 7 56 catalytic antioxidant compounds 56 antiviral compounds 56 teplizumab 56 EZN 56 receptor modulators 56 Accelerated Intelligent 56 brain penetrant 56 PSN# [002] 56 inhaled formulation 56 Viprovex TM 56 5 HT2A serotonin 56 chimeric monoclonal antibody 56 cyclin dependent kinase inhibitor 56 glucagon receptor 56 novel histone deacetylase 56 HuLuc# 56 thyroid hormone receptor 56 PRT# 56 C5aR 56 Nanobodies ® 56 Adnectins 56 SERMs 56 immune modulating 56 anti fibrotic 56 antifolate 56 nucleoside 56 IGF 1R 56 selective antagonist 56 clinically validated targets 56 polyketides 56 Carfilzomib 56 KSP inhibitor 56 PEGylation technology 56 Homspera TM 56 coupled receptor GPCR 56 XmAb ® 56 PDE4 56 PLK1 SNALP 56 5 HT2A inverse 56 lipid nanoparticles 56 PRLX # 56 mGluR5 antagonists 56 resolvin 56 PI3 kinase inhibitors 56 induces apoptosis 56 reversible inhibitors 56 Curaxin 56 PI3K/Akt pathway inhibitor 56 chemotherapeutics 56 ENMD 56 protein tyrosine phosphatase 1B 56 Janus Kinase 56 dAb 56 RNAi therapeutic targeting 56 monoclonal antibody therapeutics 56 PI3 Kinase 56 HCV protease inhibitor 56 DNA gyrase 56 Antisense 56 receptor 56 HDACs 56 Symadex 56 shRNA 56 thrombin receptor 56 GGTase 56 immunotoxin 56 Phylomer 56 CCR3 56 chronic inflammatory 56 immunotherapy 56 Like Receptor 56 systemic RNAi 56 HDACi 56 MET VEGFR2 56 UsiRNAs 56 antimitotic 56 anionic backbone 56 peroxisome proliferator activated 56 CYC# 56 preclinically 56 subtype selective 56 telomerase activator 56 Guanilib 56 Monoclonal antibodies 56 CB2 receptor 56 investigational monoclonal antibody 56 camptothecin 56 targeting PCSK9 56 tubulin inhibitors 56 delta isoform 56 selective agonist 56 poly ADP ribose polymerase 56 thrombopoietin 56 PTP 1B 56 P#X# 56 mimetic compounds 56 S#P# 56 acetylcholinesterase AChE 56 signaling pathway 56 FAAH 56 biopharmaceuticals 56 tubulin binding 56 protein tyrosine phosphatases 56 SGLT2 56 BCR ABL inhibitors 56 OXi# 56 PI3 kinase 56 NexACT 56 PNP inhibitor 56 gamma secretase inhibitor 56 epigenetic enzymes 56 Preclinical studies 56 Maribavir 56 ALK inhibitor 56 Adenosine 56 nucleic acid 56 resolvins 56 Elesclomol 56 DiLA2 55 Spiegelmer 55 Sudhir Agrawal D.Phil 55 highly selective inhibitor 55 alkylating 55 vaccine adjuvant 55 CXCR4 receptor 55 Fx #A 55 oligonucleotide therapeutics 55 ADP receptor antagonist 55 mTOR inhibitors 55 peptide antigens 55 mitotic kinesins 55 Smac mimetic 55 mAbs 55 Aurora kinase 55 gamma secretase inhibitors 55 proprietary PEGylation 55 selective androgen receptor modulator 55 MLN# 55 silico 55 allosteric 55 systemic RNAi therapeutic 55 novel topoisomerase 55 PEGylation 55 fibrotic diseases 55 receptor antagonists 55 Posiphen 55 PKC# 55 p# inhibitor 55 PDGF receptor 55 tyrosine kinase inhibitor TKI 55 siRNA mediated 55 BCR ABL 55 AtuRNAi 55 commercializing anti infective 55 PLX# 55 taxol 55 aptamer therapeutics 55 triggers apoptosis programmed 55 neuropathic pain 55 proteins peptides 55 immunologic diseases 55 Oral NKTR 55 5 HT6 antagonist 55 Anticalin ® 55 siRNA sequences 55 oral immunomodulatory 55 molecular imaging radiopharmaceuticals 55 Mipomersen 55 injectable formulation 55 activate SIRT1 55 nanomedicines 55 siRNA molecules 55 MAb 55 VEGF receptors 55 neuronal nicotinic receptor NNR 55 BRAF kinase 55 geldanamycin 55 3 kinase PI3K 55 IMiDs 55 anti mitotic 55 XmAb TM 55 HDL Mimetic Peptide 55 neuropathic pain metabolic diseases 55 sulfonylhydrazine class 55 Delta opioid receptor 55 serine protease 55 cardiovascular metabolic 55 Symphogen 55 protein kinase C 55 oncolytic viruses 55 SNALP technology 55 ion channels 55 Regado 55 protein kinases 55 nucleic acids 55 infectious diseases autoimmune diseases 55 neuro inflammatory 55 Cylene 55 theranostic 55 oral Janus kinase 55 5 HT4 receptor 55 TRV# [001] 55 Abeta# 55 rxRNA compounds 55 macrocyclic 55 IMiDs ® 55 ADME Tox 55 Factor NGF 55 small molecule activator 55 novel antibody therapeutics 55 immunosuppressive 55 inhibit viral replication 55 RONDEL TM 55 promising anticancer 55 proteases 55 mGluR2 NAM 55 metabotropic glutamate receptor 55 Onconova 55 immunological diseases 55 #HT# 55 Dyax phage display 55 myelofibrosis polycythemia vera 55 TELINTRA 55 pharmacokinetic properties 55 Litx 55 immunomodulators 55 Chrysalin 55 antibody therapies 55 potent anticancer 55 insulin sensitizer 55 gallium containing 55 Amigal 55 anti angiogenic drugs 55 Cellzome 55 inhibit KSP 55 metalloenzymes 55 ghrelin antagonist 55 chemokine 55 Sphingomab 55 TÎ ² 4 55 bacterial enzyme 55 vidofludimus 55 Tß4 55 metaglidasen 55 5 HT6 receptor 55 inhibitors 55 #HT#A 55 mu opioid receptor antagonist 55 LentiVector technology 55 RAF kinase 55 optimized siRNA 55 immune modulator 55 chemotherapy induced neutropenia 55 intranasal delivery 55 autoimmune diseases 55 XmAb 55 macrocycles 55 Phylomer ® 55 SMARTICLES ® 55 Angiocept 55 CCX# 55 EGFR HER 55 Atiprimod 55 CD# antibody [001] 55 Crizotinib 55 receptor modulator 55 PORxin 55 intranasal insulin product 55 Abiraterone acetate 55 candidate deforolimus 55 investigational compound 55 Wnt signaling pathway 55 potently inhibited 55 estrogen receptor beta 55 acting muscarinic antagonist 55 BMS # 55 drug conjugate 55 compound PMX # 55 HGS# 55 bioactive 55 SGLT 2 55 biologic therapies 55 LEX System 55 enzymes 55 CYT# novel 55 developing Zerenex TM 55 chemogenomics 55 IgG1 antibody 55 fatty acid amide hydrolase 55 antibody fragments 55 kinase PI3K 55 cyclin dependent kinases 55 integrative pharmacology 55 GPR# agonists 55 autologous cell 55 Bcl 2 55 neuroprotective 55 CD# monoclonal antibody 55 vaccine GRNVAC1 55 SPC# [001] 55 AMPK activators 55 neurotrophic factor 55 ATL# [002] 55 AZD# 55 oligonucleotides 55 nanoparticle 55 AKIP ™ 55 kinase profiling 55 ALV# 55 phosphoinositide 3 55 Affibody ® molecules 55 ENaC 55 gamma secretase 55 Janus kinase 55 solid tumors 55 Hsp# [002] 55 Cyclosert TM 54 peptidomimetic 54 dasatinib Sprycel 54 PDE# 54 receptor partial agonist 54 cytotoxin 54 U1 Adaptors 54 infectious diseases autoimmune 54 TG# [003] 54 ApoB SNALP 54 transfection reagents 54 vanilloid receptor 54 nanocarriers 54 RNA interference RNAi therapeutics 54 Beta catenin 54 MAXY G# 54 otelixizumab 54 telomerase inhibitor 54 ZFNs 54 chemotherapeutic 54 prostanoid 54 kinase inhibition 54 HuCAL antibody 54 ZFP technology 54 SGLT Inhibitors 54 EGF receptor 54 phosphate S1P 54 ATHX 54 ETBs 54 XL# XL# 54 RECOTHROM R 54 Pancreate 54 selective immunoproteasome inhibitor 54 Ambrx 54 Small Molecule 54 Aurora kinase inhibitor 54 TKM ApoB 54 non nucleoside 54 Gleevec resistant 54 c MET 54 imatinib Gleevec ® 54 cyclophilin inhibitor 54 AQ4N 54 secretase 54 Tumor Necrosis Factor 54 Pertuzumab 54 hypoxia activated prodrug 54 CK # novel 54 selective relaxant 54 Liposomal 54 proteins 54 pro angiogenic 54 sd rxRNA 54 Vascular Endothelial Growth 54 #/#/# Cytokinetics Incorporated 54 photosensitizer 54 mTOR inhibitor 54 P#X# antagonist 54 beta lactam 54 biosurgical 54 CA4P 54 anti CD# antibody 54 mimetics 54 Isogenica 54 Peptide 54 topoisomerase 54 antisense compounds 54 Vorinostat 54 Maxy G# 54 Tasimelteon 54 tyrosine kinase inhibitors 54 nucleoside analog 54 tafamidis 54 intranasal formulation 54 Anidulafungin 54 polymer conjugate technology 54 novel antifolate 54 kinases 54 selective modulator 54 reformulates existing FDA 54 potentiator 54 enzyme beta secretase 54 NovaBay Aganocide compounds 54 diagnostic molecular imaging 54 proprietary phage display 54 receptor subtype 54 renin inhibitor 54 ribonuclease 54 Cyclooxygenase Inhibiting Nitric Oxide 54 5 HT4 54 inhibits protein synthesis 54 non nucleoside inhibitor 54 Tarmogen 54 preclinical efficacy 54 TRAIL receptor 54 Cannabinor 54 galectin 54 Sphingomab TM 54 Spiegelmers 54 CORT # 54 TNF receptors 54 xenograft models 54 Voreloxin 54 NP2 Enkephalin 54 GMX# 54 orally dosed 54 Intermezzo ® zolpidem tartrate 54 High Impact AMPAKINE 54 Gamma secretase 54 RONDEL ™ 54 DsiRNA 54 Sapacitabine 54 Chronogen 54 cannabinoid 54 molecular imaging radiopharmaceutical 54 vivo RNAi 54 SCYNEXIS 54 peptide conjugated 54 RNA interference 54 anti angiogenic agent 54 Daclizumab 54 mertansine 54 siRNAs targeting 54 2 methoxyestradiol 54 MT#/MEDI-# 54 peptidic compound 54 hedgehog pathway 54 chemotherapeutic drugs 54 chemotherapeutic drug 54 biobetter 54 aurora kinase 54 immunomodulating 54 biologic therapy 54 serotonin receptor 54 mGluR4 54 selective inverse agonist 54 DHFR 54 SGLT2 inhibitors 54 echinocandins 54 ProNAi 54 ophthalmic diseases 54 Phase IIb clinical trials 54 affinity antibodies 54 carbohydrate compounds 54 MediVas 54 orally administered inhibitor 54 kidney urologic 54 maytansinoid 54 fusion inhibitors 54 Trophos 54 biocatalysis 54 chemical entities NCEs 54 Nanobodies R 54 hormone LHRH antagonist 54 telomerase activators 54 synthetic anti infective 54 secreted protein 54 anti amnesic 54 oral Factor Xa 54 gastro intestinal inflammation 54 GelSite R polymer 54 non nucleoside HCV 54 factor receptor FGFR 54 predictive toxicology 54 GAP #B# 54 PROT biotechnology 54 Genedata Expressionist ® 54 highly selective endothelin 54 recombinant fusion 54 Miraxion Amarin lead 54 dendritic cell 54 NAGS deficiency 54 milatuzumab 54 novel immunotherapies 54 therapies 54 Annamycin 54 Nuron Biotech 54 CDK inhibitors 54 generation purine nucleoside 54 c Raf kinase 54 cyclic peptide 54 anticancer compound 54 targeted radiotherapeutics 54 acetylcholinesterase 54 lipidoid 54 biomarker assays 54 protein misfolding 54 microRNA 54 lipid nanoparticle 54 Semafore 54 Nasdaq LXRX biopharmaceutical 54 accumulate preferentially 54 nitric oxide donating prostaglandin 54 Chemokine 54 single stranded oligonucleotides 54 ZFP TF 54 NASDAQ SNTA biopharmaceutical 54 Intellikine 54 JAK#/JAK# 54 ZFPs 54 seliciclib CYC# 54 targets Galectin receptors 54 GSK3B 54 Galectin 54 Myolimus 54 chemotherapeutic agents 54 muscarinic receptor agonist 54 bortezomib Velcade 54 ERK1 2 54 morpholino 54 Triphendiol 54 TNFa 54 BAL# [001] 54 AN# novel 54 amino acid peptide 54 integrin receptors 54 compound perifosine 54 eligen R technology 54 systemic siRNA 54 ZFP TFs 54 membrane receptors 54 Chemokine Receptor 54 Exelixis compounds 54 therapeutic mAbs 54 Bevasiranib 54 aurora kinase inhibitor 54 small molecule thrombopoietin 54 VEGF Trap 54 azoles 53 coupled receptors GPCRs 53 beta amyloid peptide 53 lipid mediators 53 Calistoga Pharmaceuticals 53 cortisol synthesis 53 novel synthetic peptide 53 obatoclax 53 liposome encapsulated 53 topical dermatology 53 recombinant polyclonal antibodies 53 prostones 53 KRN# 53 XmAb# 53 cholesteryl ester transfer 53 TLR antagonists 53 MetAP2 53 vitamin D analogs 53 inhibitor PPI 53 Isis antisense 53 Survivin 53 TRC# 53 inhibit telomerase 53 Cdc7 53 intracellular protein 53 PPARγ 53 BAY #-# 53 allosteric modulators 53 glycosylated 53 ubiquitin ligase